tiprankstipranks
Acasti Pharma, Inc. (TSE:ACST)
TSXV:ACST

Acasti Pharma (ACST) Stock News & Sentiment

0 Followers
Acasti Pharma: WuXi Clinical to conduct STRIVE-ON Phase 3 trial for GTX-104
PremiumThe Fly
Acasti Pharma: WuXi Clinical to conduct STRIVE-ON Phase 3 trial for GTX-104
9M ago
Acasti Pharma announces 1-for-6 reverse stock split
PremiumThe Fly
Acasti Pharma announces 1-for-6 reverse stock split
10M ago
Acasti Pharma announces alignment with FDA on GTX-104 Phase 3 safety trial
PremiumThe Fly
Acasti Pharma announces alignment with FDA on GTX-104 Phase 3 safety trial
10M ago
Acasti Pharma Reports Fiscal Year 2023 Operational Results
PremiumPress Releases
Acasti Pharma Reports Fiscal Year 2023 Operational Results
10M ago
Acasti Pharma to proceed with Phase 3 study of GTX-104
PremiumThe Fly
Acasti Pharma to proceed with Phase 3 study of GTX-104
1y ago
Acasti Pharma names Prashant Kohli as CEO, succeeding Jan D’Alvise
PremiumThe Fly
Acasti Pharma names Prashant Kohli as CEO, succeeding Jan D’Alvise
1y ago
Acasti Pharma to delist shares on TSXV, confirms no exposure to SVB
PremiumThe Fly
Acasti Pharma to delist shares on TSXV, confirms no exposure to SVB
1y ago
More ACST News >

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TSE:ACST’s Media Buzz Sentiment?
Currently, no data Available
What is TSE:ACST’s weekly average amount of articles?
Currently, no data Available
What is TSE:ACST’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
JANXJanux Therapeutics Inc
BDXBecton Dickinson
RVTYRevvity
AVCRFAvricore Health
BGLCBioNexus Gene Lab Corp
Showing the stocks with the most bullish news sentiment over the past week
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis